Help-Line 01233 334879

 

Proventus

Making Life Fairer

 

Working Together to Make a Difference

UK Charity No 1131517

Working together to make a difference

We are a member of the Fund Raising Standards Board

 

We are all volunteers and the advice we receive is also given freely.

 

All donations are used to further the work we do.

Please Donate

 

Join Us

 

Provide Support

Buy At

 

UK Charity

No 1131517

 

Copyright © Proventus 2010

 

Terms & Conditions

 

Multiple Sclerosis

It is important to remember that MS is only one part of a person and not the person.

MS does not represent them, it is not their identity, they are as normal as the next person.  

Find Us Here

You tube
Follow Provpeter on Twitter
You Tube
twitter

Off licence Drugs & MS                                                                                                                                                                                       

Under certain special conditions, medicines can be prescribed on an individual patient basis, (named patient basis) where there is a particular reason, for a condition or use where the medicine does not have a marketing authorisation.

 

This is known as 'off licence' or 'unlicensed' prescribing, and this sometimes happens in MS.

 

Off licence prescribing is used in special circumstances and should be fully discussed with your specialist. Medicines, which meet the standards of safety, quality and efficacy, are granted a marketing authorisation, which is necessary before they may be prescribed or sold.

This can be granted either by a government body called the Medicines and Healthcare Products Regulatory Agency (MHRA) or by a European authority (EMEA) under the European regulatory process.

 

The regulatory authority (either the MHRA or an European authority) carries out an assessment of the medicine's safety, quality and efficacy, examining all the research and test results in detail, before a decision is made on whether the product should be granted a marketing authorisation. The authorisation which is issued defines who the drug can be prescribed to, and for what conditions and uses.

 

Because MS is considered to be an autoimmune disease (this has yet to be proven) drugs which are licensed for the treatment of other autoimmune diseases such as rheumatoid arthritis and psoriasis, are occasionally prescribed off-licence to people with MS.

 

Most of these drugs are immunomodulators.

 

Immunomodulators which might be prescribed include:

 

 

1. Yudkin1991.

 

 

Top of Page